EVH
Evolent Health, Inc.
EVH lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover, though they disagree widely on how much.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
EVH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Stable | |
| Weak |
EVH's revenue is currently healthy, and its cash flow is stable, but its profitability and balance sheet are weak.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
EVH PE Valuation
EVH has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
EVH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
EVH has the edge over HIMS on the outlook, with more favorable earnings expectations.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
EVH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.40 | — |
| Q3 2026 | -$4.54 | -$2.96 |
| Q2 2026 | -$4.57 | -$2.96 |
| Q1 2026 | -$4.76 | -$3.53 |
| Q4 2025 | -$5.15 | -$4.33 |
| Q3 2025 | -$1.58 | -$0.67 |
| Q2 2025 | -$1.61 | -$0.67 |
| Q1 2025 | -$1.23 | +$0.02 |
| Q4 2024 | -$0.82 | +$0.45 |
EVH is still losing money, but less than at its worst: $4.54 per share over the past year, against $6.11 at its worst in late 2020.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over EVH on earnings, with more consistent year-over-year improvement.
EVH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $725.4M | +51% |
| Q2 2026 | $652.5M | +47% |
| Q1 2026 | $496.2M | +2.6% |
| Q4 2025 | $468.7M | -28% |
| Q3 2025 | $479.5M | -23% |
| Q2 2025 | $444.3M | -31% |
| Q1 2025 | $483.6M | -24% |
| Q4 2024 | $646.5M | +16% |
EVH's revenue is growing: $725M last quarter, up 51% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.8% | -1 points |
| Q2 2026 | -1.5% | -1.2 points |
| Q1 2026 | -2.1% | -1.8 points |
| Q4 2025 | -87% | -84 points |
| Q3 2025 | 0.2% | +2.8 points |
| Q2 2025 | -0.3% | -1.5 points |
| Q1 2025 | -0.3% | +1.8 points |
| Q4 2024 | -2.9% | +1 points |
EVH has the edge over HIMS on profitability, with a higher operating margin.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over EVH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
EVH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26.4M | +67% |
| Q2 2026 | -$9.3M | +$21M |
| Q1 2026 | -$984K | -122% |
| Q4 2025 | $48.8M | +$75M |
| Q3 2025 | $15.8M | -15% |
| Q2 2025 | -$30.3M | -242% |
| Q1 2025 | $4.6M | -7% |
| Q4 2024 | -$26.2M | -129% |
EVH's free cash flow has turned positive again: $65M over the past year, against −$36M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over EVH on cash flow, with more consistent year-over-year improvement.
EVH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +529K shares |
| 1 year | -0.9% | -995K shares |
| 3 years | +0.7% | +789K shares |
| 5 years | +32% | +27.3M shares |
| Available history | +37% | +30.7M shares |
EVH has 113M diluted shares, down 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over EVH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
EVH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 11.9x | High |
| Q2 2025 | 9.8x | High |
| Q1 2025 | 6.8x | High |
| Q4 2024 | 7.2x | High |
| Q3 2024 | 6.7x | High |
| Q2 2024 | 6.5x | High |
| Q1 2024 | 8.8x | High |
| Q4 2023 | 7.7x | High |
EVH's net debt is about 12 years of its operating earnings (EBITDA), up from 6.7 years a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
EVH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
EVH's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
EVH PE vs Healthcare Sector
EVH has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
EVH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.27 | 12% above |
| 20 week MA | $4.45 | 7.2% above |
| 50 week MA | $3.92 | 22% above |
| 100 week MA | $6.50 | 27% below |
| 200 week MA | $17.2 | 72% below |
EVH has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
EVH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.85 | $16.3 | +84% |
| 2021 | $16.3 | $27.0 | +66% |
| 2022 | $27.0 | $27.3 | +1.3% |
| 2023 | $27.3 | $33.0 | +21% |
| 2024 | $33.0 | $11.1 | -66% |
| 2025 | $11.1 | $4.12 | -63% |
| 2026 YTD | $4.12 | $4.77 | +16% |
EVH has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.